Literature DB >> 21119372

Fertility preserving management in gynecologic cancer patients: the need for centralization.

Vesna Kesic1, Alexandros Rodolakis, Dominik Denschlag, Achim Schneider, Philippe Morice, Frederic Amant, Nicholas Reed.   

Abstract

Preservation of fertility has became a very important issue in gynecologic oncology. It is a result of both the increasing incidence of gynecologic cancer in young patients and the increasing age at first pregnancy. Today, in a young patient with a gynecologic cancer, preservation of fertility is possible and depends primarily on the extent and type of cancer. The clinical importance of an appropriate management of young patients with gynecologic cancer has lead the ESGO Task Force for Fertility Preservation in Gynecologic Cancer to conduct a survey with the aim of exploring the numbers and eligibility of gynecologic cancer patients for fertility-sparing treatment in selected gynecologic oncology centers across Europe. A questionnaire designed to allow adequate insight into the number of patient eligible for fertility-sparing treatment and the resulting treatment was sent to 20 ESGO-accredited centers. The data were collected retrospectively for the year 2007. The reply was received from 14 gynecologic oncology centers, and those surveys were included for analysis. The small numbers of patients eligible for conservative management (14-15 per year/median number in ESGO-accredited centers) and even the smaller number of those who actually receive fertility-sparing treatment (<10) raise the question of quality of care for these patients. These low numbers support the concept of centralization for fertility-sparing management to improve the quality of patients care. Since carrying out the survey on fertility-sparing management in ESGO-accredited gynecologic oncology centers in Europe, the ESGO Task Force for Fertility Preservation in Gynecologic Cancer has proposed a protocol for referrals to centralized units that have developed specific expertise. Optimal management for young patients with gynecologic cancer should include a clear decision-making process, an adequate counseling about the future oncological and obstetrical risks, the appropriate management, and a careful follow-up within a multidisciplinary setting.

Entities:  

Mesh:

Year:  2010        PMID: 21119372     DOI: 10.1111/IGC.0b013e3181f936ff

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  8 in total

Review 1.  Current imaging strategies for the evaluation of uterine cervical cancer.

Authors:  Charis Bourgioti; Konstantinos Chatoupis; Lia Angela Moulopoulos
Journal:  World J Radiol       Date:  2016-04-28

2.  Fertility preservation treatment of gynecological cancer patients in Spain: a national survey (GOFER study).

Authors:  Mikel Gorostidi; Blanca Gil-Ibañez; Sonsoles Alonso; Antonio Gil-Moreno; Alicia Hernandez; Aureli Torné; Ignacio Zapardiel
Journal:  Arch Gynecol Obstet       Date:  2020-03-02       Impact factor: 2.344

Review 3.  Fertility-sparing approaches in gynecologic cancers: a review of ESGO task force activities.

Authors:  Dominik Denschlag; Nicholas S Reed; Alex Rodolakis
Journal:  Curr Oncol Rep       Date:  2012-12       Impact factor: 5.075

4.  SEOM Clinical Guideline of fertility preservation and reproduction in cancer patients (2016).

Authors:  M Muñoz; A Santaballa; M A Seguí; C Beato; S de la Cruz; J Espinosa; P J Fonseca; J Perez; T Quintanar; A Blasco
Journal:  Clin Transl Oncol       Date:  2016-11-28       Impact factor: 3.405

Review 5.  Fertility preservation during cancer treatment: clinical guidelines.

Authors:  Kenny A Rodriguez-Wallberg; Kutluk Oktay
Journal:  Cancer Manag Res       Date:  2014-03-04       Impact factor: 3.989

Review 6.  The Relevance of Gynecologic Oncologists to Provide High-Quality of Care to Women with Gynecological Cancer.

Authors:  Lucas Minig; Pablo Padilla-Iserte; Cristina Zorrero
Journal:  Front Oncol       Date:  2016-01-14       Impact factor: 6.244

Review 7.  Fertility preservation in women with cervical, endometrial or ovarian cancers.

Authors:  Michael Feichtinger; Kenny A Rodriguez-Wallberg
Journal:  Gynecol Oncol Res Pract       Date:  2016-07-27

8.  Tumor Size at Magnetic Resonance Imaging Association With Lymph Node Metastasis and Lymphovascular Space Invasion in Resectable Cervical Cancer: A Multicenter Evaluation of Surgical Specimens.

Authors:  Xiao-Li Chen; Guang-Wen Chen; Guo-Hui Xu; Jing Ren; Zhen-Lin Li; Hong Pu; Hang Li
Journal:  Int J Gynecol Cancer       Date:  2018-10       Impact factor: 3.437

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.